Asciminib
FDA Grants Accelerated Approval to Scemblix for Newly Diagnosed Chronic Myeloid Leukemia
The FDA granted accelerated approval to asciminib (Scemblix, Novartis AG) for adult patients with newly diagnosed ...
OCTOBER 30, 2024
FDA Approves Scemblix to Treat Ph-Positive CML in Chronic Phase
The FDA granted accelerated approval for use of asciminib (Scemblix, Novartis) in the treatment of patients with ...
NOVEMBER 8, 2021
Load more